Ads
related to: acute myeloid leukemia- Safety
Learn More About Well Characterized
Safety Profile.
- Dosing & Monitoring
Twice Daily
Oral Dosing.
- Efficacy
Durable Complete Remissions
for R/R AML Patients.
- Mechanism of Action
Inhibits Mutant IDHI and
Restores Myeloblast Differentiation
- Safety
Search results
7 Biotech Stocks to Put on Your Breakthrough Radar
InvestorPlace· 24 hours agoFor those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower....
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
WROC Rochester· 5 days agoOral presentation of final five-year results from the registrational Phase 2 trial in R/R mIDH1 AML patients reinforces REZLIDHIA® (olutasidenib) efficacy in heavily pretreated patients, including ...
Dallas teen who inspired hundreds to register to become blood stem cell donors dies
FOX 4 News Dallas - Fort Worth· 2 days agoA 13-year-old Dallas boy fighting an aggressive form of leukemia hopes his story will inspire people...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 5 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Syrian first lady diagnosed with leukemia
China Daily· 7 days agoSyrian First Lady Asma al-Assad has been diagnosed with acute myeloid leukemia, a type of blood cancer, the Syrian presidency said in ...
GlycoMimetics (NASDAQ:GLYC) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 5 days agoStockNews.com assumed coverage on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a research note released on Wednesday. The firm issued a sell rating on the biotechnology company’s stock ...
All over the body: Here are the key clinical trials from Bay Area firms - San Francisco Business...
The Business Journals· 4 days agoSince the turn of the millennium, Bay Area organizations and researchers have launched more than 300...
Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal...
Centers for Disease Control and Prevention· 5 days agoWe describe an underrecognized Scedosporium spp. and Lomentospora prolificans vascular tropism requiring specific management of which clinicians should be aware.
Innovative Techniques Open New Avenues in Drug Dis | Newswise
Newswise· 5 days agoVolume 29, Issue 2 of SLAS Discovery features two review articles, six original research articles...
NCI-MATCH Precision Medicine Clinical Trial
National Cancer Institute· 5 days agoNCI-MATCH, also known as MATCH, is a precision medicine cancer treatment clinical trial that sought to find out if treating cancer based on specific...
Ads
related to: acute myeloid leukemia